Core Insights - Suzhou Pusi Imaging Medical has completed nearly 100 million RMB in Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Investment [1] - The company, founded in 2021, focuses on the research and industrialization of core components and complete systems for magnetic resonance imaging (MRI), utilizing innovative technologies to reduce reliance on liquid helium [1] - The founder, Dr. Ni Zhipeng, has a strong background in superconducting magnet research and has achieved breakthroughs in this field during his tenure at various prestigious institutions [1][2] Company Overview - Pusi Imaging Medical aims to develop domestically produced low-liquid-helium superconducting magnet technology to achieve a technological leap [2] - The proprietary PhaseXCool® technology developed by the company effectively transfers heat between the GM cold head and key components inside the magnet through the gas-liquid phase change of helium, ensuring stable operation of the magnet [2] - The company has completed three rounds of financing to date [3]

Core Insights - Suzhou Pusi Ying Medical recently completed nearly 100 million yuan Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Investment [1] - The funding will accelerate the industrialization and expansion of the low helium siphon cooling technology PhaseXCool® in three main areas: medical MRI equipment, industrial magnetic single crystal superconducting systems, and precision scientific instruments [1] Company Overview - The founder, Dr. Ni Zhipeng, has a career focused on superconducting magnets, achieving breakthroughs in superconducting magnet research at institutions such as the Chinese Academy of Sciences and Philips Healthcare [1] - Pusi Ying Medical aims to develop domestic low liquid helium superconducting magnet technology to achieve technological advancement [1] Technology Breakthrough - The new generation of low liquid helium magnets eliminates excessive reliance on liquid helium by using a GM refrigerator secondary cold head (3-4K) as a cooling source, achieving efficient heat exchange for key components of the magnet [2] - The technology allows superconducting magnets to operate stably below 4.2K without liquid helium consumption, relying on a closed pipeline and heat exchanger for self-driven cooling [2] Structural and Cost Advantages - The new technology features structural design optimizations that reduce weight by nearly half, from 4.5-6 tons to approximately 3 tons, lowering manufacturing and installation barriers [2] - For hospitals, this means reduced infrastructure requirements, more flexible installation, and lower maintenance costs, while the overall operational costs can decrease by 50% due to significant savings on liquid helium [2]

Company Overview - Suzhou Pusi Medical recently completed nearly 100 million yuan in Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Technology [1] - The funding will accelerate the industrialization of the low helium siphon cooling technology PhaseXCool® in superconducting magnet devices, including MRI equipment, industrial magnetic single crystal systems, and precision scientific instruments [1] Technology and Innovation - The core breakthrough of Pusi Medical's new generation low helium magnet is the reduced reliance on liquid helium, utilizing a GM cooler secondary cold head (3-4K) as a cooling source [3] - The PhaseXCool® technology achieves effective heat exchange for key components of the magnet, allowing stable operation below 4.2K with significantly lower helium consumption [2][3] - The new technology features a closed-loop self-circulation system that eliminates helium leakage and quenching risks, reducing downtime recovery to one-third of traditional equipment [4] Market Potential - The global MRI equipment market is projected to grow from approximately $7.1 billion in 2024 to $10.3 billion by 2030, indicating a strong growth trajectory [6] - The low helium MRI market is expected to expand from $2.8 billion in 2024 to $5.9 billion by 2033, highlighting the demand for this innovative technology [6] - Pusi Medical plans to deliver the first batch of 3.0T low helium superconducting magnets for system testing to domestic clients by June next year, with industrial magnetic single crystal magnets expected by the end of the year [5]

Core Viewpoint - Pusiying Medical aims to deliver the first batch of 3.0T low-liquid helium superconducting magnets to major domestic clients by June next year, focusing on the industrialization of its PhaseXCool® technology in MRI equipment and other fields [2][9]. Financing and Technology Development - Pusiying Medical recently completed nearly 100 million yuan in Series A financing, led by Ivy Capital, with participation from existing shareholder Neusoft Capital and Xiaoming Technology. The funds will accelerate the industrialization of low-helium siphon cooling technology [3]. - The founder, Dr. Ni Zhipeng, has a strong background in superconducting magnet research, having led significant projects in this field [3][4]. Challenges of Traditional MRI Technology - Traditional MRI technology relies on liquid helium, which is a non-renewable and scarce resource, with over 95% of China's helium imported, primarily from the US and Russia. This poses risks to high-end medical equipment manufacturing in China [4]. - The cost of liquid helium has surged from 20-30 yuan per liter to 200-300 yuan per liter, leading to operational costs for a 3.0T MRI device reaching millions, comparable to manufacturing costs [4][5]. Innovations in Low-Helium Technology - Pusiying Medical's PhaseXCool® technology reduces reliance on liquid helium by using a GM cooler as a cold source, achieving efficient heat exchange for superconducting components [5][6]. - The new superconducting magnets can operate stably below 4.2K with significantly reduced liquid helium consumption, leading to a 50% reduction in overall operational costs [6][7]. Applications and Market Potential - The low-helium technology has potential applications beyond MRI, including in MR-Linac systems for cancer treatment and high-field MRI systems for brain research, which are currently expensive due to helium costs [8]. - The global MRI equipment market is projected to grow from approximately $7.1 billion in 2024 to $10.3 billion by 2030, with the low-helium MRI market expected to expand from $2.8 billion in 2024 to $5.9 billion by 2033 [9].